George Washington University

Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update

Retrieved on: 
Tuesday, April 2, 2024

MARLBOROUGH, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today reported its financial results for the year ended December 31, 2023 and provided a business update.

Key Points: 
  • The latter clearance was significant since there are no drugs specifically approved to treat early stages I and II of cSCC.
  • As of February, the first two patients in our first cohort have completed treatment with PH-762 with no reported adverse events.
  • In 2023 we implemented a cost rationalization program driven by our transition from discovery research to product development.
  • At December 31, 2023 we had cash of $8.5 million as compared with $11.8 million at December 31, 2022.

FOR IMMEDIATE RELEASE: The Global FoodBanking Network Welcomes Vanessa Garcia as Chief Financial Officer

Retrieved on: 
Monday, April 1, 2024

“After a thorough and rigorous search, we are thrilled to welcome Vanessa Garcia to The Global FoodBanking Network,” said CEO Lisa Moon.

Key Points: 
  • “After a thorough and rigorous search, we are thrilled to welcome Vanessa Garcia to The Global FoodBanking Network,” said CEO Lisa Moon.
  • “Joining The Global FoodBanking Network as Chief Financial Officer is a pivotal moment in my career, blending my personal mission with my professional journey.
  • Garcia will be taking over the Chief Financial Officer position from Beth Saks, who has been part of The Global FoodBanking Network team for more than 15 years.
  • The Global FoodBanking Network extends our deepest thanks to Saks for enabling us to do such critical work year after year.

Leading Biometric Identify Verification & Authentication Firm authID Inc. Appoints Kunal Mehta to its Board of Directors

Retrieved on: 
Tuesday, March 26, 2024

DENVER, March 26, 2024 (GLOBE NEWSWIRE) -- authID.ai [Nasdaq: AUID], a leading provider of innovative biometric identity verification and authentication solutions, today announced the appointment of Kunal Mehta to its Board of Directors, effective immediately. Mehta, a partner at Bain & Company, adds deep expertise in strategic growth areas targeted by authID: market expansion, go-to-market (GTM) strategy, and operational efficiency.

Key Points: 
  • Mehta, a partner at Bain & Company, adds deep expertise in strategic growth areas targeted by authID: market expansion, go-to-market (GTM) strategy, and operational efficiency.
  • “Kunal led Revenue Operations, Marketing, and Enablement teams, gaining valuable expertise that can help authID scale.
  • I am honored to join the authID Board and look forward to helping drive the Company’s growth,” said Director Kunal Mehta.
  • Currently, Mehta consults with some of the leading private equity (PE) and PE-backed companies at Bain & Company.

AffyImmune Therapeutics Announces Clinical and Regulatory Advisory Board to Support Development of AIC100 in Solid Tumors

Retrieved on: 
Monday, April 8, 2024

The CRAB will provide strategic counsel and expertise as AffyImmune advances its affinity-tuned CAR T therapeutics in clinical development.

Key Points: 
  • The CRAB will provide strategic counsel and expertise as AffyImmune advances its affinity-tuned CAR T therapeutics in clinical development.
  • “This group of distinguished scientists and advisors bring to AffyImmune invaluable CAR T drug development experience from research to commercialization,” said Sonal Gupta, MD, PhD, AffyImmune SVP and Head of Clinical Development.
  • ‘’I am honored to join Affylmmune’s Clinical and Regulatory Advisory Board and look forward to working with the other members to advance the development of novel treatments,” said Carmelo Nucera, MD, PhD.
  • Jorge J. Nieva, MD , Associate Professor of Clinical Medicine, Keck School of Medicine, University of Southern California and Section Head, Solid Tumors, USC/Norris Cancer Center.

Guidehouse Honored with Don Strong Community Partner Award for 2024 by George Washington University Milken Institute School of Public Health

Retrieved on: 
Tuesday, April 9, 2024

WASHINGTON, April 9, 2024 /PRNewswire/ -- Guidehouse , a leading global provider of strategy and managed services to commercial and public sector clients, is proud to announce it has been chosen as the recipient of the Don Strong Community Partner Award for 2024 by the George Washington University Milken Institute School of Public Health (SPH).

Key Points: 
  • WASHINGTON, April 9, 2024 /PRNewswire/ -- Guidehouse , a leading global provider of strategy and managed services to commercial and public sector clients, is proud to announce it has been chosen as the recipient of the Don Strong Community Partner Award for 2024 by the George Washington University Milken Institute School of Public Health (SPH).
  • The Don Strong Community Partner Award is presented to organizations that demonstrate exceptional dedication to advancing public health initiatives and promoting the well-being of communities worldwide.
  • Guidehouse received this prestigious recognition in support of its partnership with the Milken Institute SPH, and steadfast support of the school's mission to educate and train future leaders in public health.
  • Guidehouse was celebrated at the Community Partner Appreciation Event on April 4 at the Milken Institute SPH.

Stoke Space Names Retired U.S. Space Force Lt. Gen. John E. Shaw to Board of Directors, Paul Croci as Chief Financial Officer

Retrieved on: 
Monday, April 8, 2024

KENT, Wash., April 8, 2024 /PRNewswire/ -- Today Stoke Space announced that the company has appointed retired U.S. Space Force Lt. Gen. John E. Shaw to its Board of Directors and Paul Croci as its chief financial officer.

Key Points: 
  • KENT, Wash., April 8, 2024 /PRNewswire/ -- Today Stoke Space announced that the company has appointed retired U.S. Space Force Lt. Gen. John E. Shaw to its Board of Directors and Paul Croci as its chief financial officer.
  • In this role, Shaw advocated for the U.S. Space Force to pursue advanced capabilities that enable dynamic space operations in which in-space assets can actively maneuver without constraint.
  • "Stoke Space is a highly innovative and motivated team with a compelling vision for reusable and sustainable space capabilities," Shaw said.
  • "It is an incredibly exciting opportunity as Stoke Space is well positioned to grow rapidly in the emerging new space economy."

Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research

Retrieved on: 
Wednesday, March 13, 2024

Banner MD Anderson Cancer Center in Gilbert, Arizona

Key Points: 
  • Banner MD Anderson Cancer Center in Gilbert, Arizona
    Integrity Research Clinical Associates in Delray Beach, Florida
    These sites join Centricity Research in Dublin, Ohio, which enrolled the study’s first patient in November.
  • The principal investigator at the George Washington University trial is Vishal Patel, M.D.
  • at the Banner MD Anderson Cancer Center trial site.
  • More information about this clinical trial is available at clinicaltrials.gov (identifier: NCT06014086 ).

egnite, Inc. Announces the Appointment of Vinod Thourani and Nicholas Amoroso to Its Medical Advisory Board

Retrieved on: 
Tuesday, March 26, 2024

egnite, Inc. , a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD, to its Medical Advisory Board .

Key Points: 
  • egnite, Inc. , a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD, to its Medical Advisory Board .
  • His involvement in novel clinical trials and contributions to leading cardiology research brings a wealth of experience to egnite’s medical advisory board.
  • "We are honored to welcome Vinod and Nick to egnite’s Medical Advisory Board," said Joel Portice, president and CEO of egnite.
  • The appointment of Thourani and Amoroso to its Medical Advisory Board underscores egnite’s commitment to excellence and advancement in developing solutions to address the evolving needs of cardiovascular patients and providers.

Google Cloud’s CISO Phil Venables and Mandiant CEO Kevin Mandia to Headline Cloud Security Alliance AI Summit at 2024 RSA Conference

Retrieved on: 
Tuesday, March 26, 2024

The Cloud Security Alliance (CSA), the world’s leading organization dedicated to defining standards, certifications, and best practices to help ensure a secure cloud computing environment, today announced that Google Cloud’s Kevin Mandia, CEO of Mandiant, and Phil Venables, Chief Information Security Officer (CISO), will headline the CSA AI Summit , held on May 6 in conjunction with the 2024 RSA Conference .

Key Points: 
  • The Cloud Security Alliance (CSA), the world’s leading organization dedicated to defining standards, certifications, and best practices to help ensure a secure cloud computing environment, today announced that Google Cloud’s Kevin Mandia, CEO of Mandiant, and Phil Venables, Chief Information Security Officer (CISO), will headline the CSA AI Summit , held on May 6 in conjunction with the 2024 RSA Conference .
  • “Everyone can learn volumes from the first-hand experiences that Kevin and Phil will be sharing about working with AI at scale,” said Caleb Sima, chair of CSA’s AI Safety Initiative.
  • Phil Venables is the CISO of Google Cloud, where he leads the risk, security, compliance, and privacy teams.
  • Kevin Mandia is the CEO of Mandiant at Google Cloud.

Summit Partners Announces Promotions and Additions to Global Investment Team

Retrieved on: 
Tuesday, March 19, 2024

Summit Partners, a leading alternative investment firm, today announced the promotion of three professionals and the addition of one new Principal across the firm’s global offices.

Key Points: 
  • Summit Partners, a leading alternative investment firm, today announced the promotion of three professionals and the addition of one new Principal across the firm’s global offices.
  • “We are very pleased to recognize the performance of these three colleagues with well-earned promotions,” said Peter Chung , Managing Director and Chief Executive Officer of Summit Partners.
  • Prior to Summit, Hanyin worked on the Technology, Media and Telecommunications Group at UBS Investment Bank.
  • Prior to Summit, Cody was a partner at Lever & Dial, an investment and advisory firm dedicated to helping growth companies scale with world-class marketing.